GlassScriptPhysician profile
Sally W Pullman Mooar
NPI 1912930702
$1,819.83
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.75 · 2020: $324 · 2021: $148 · 2022: $113 · 2023: $659 · 2024: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.57 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $400.91 | 2021-2024 | Tremfya, Simponi Aria |
| Abbvie INC. | $298.62 | 2019-2024 | |
| Amgen INC. | $201.86 | 2020-2024 | Prolia, Otezla, Enbrel |
| Genentech USA, INC. | $163.26 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $158.86 | 2021-2024 | Orencia |
| Novartis Pharmaceuticals Corporation | $158.01 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $88.99 | 2021-2023 | Saphnelo |
| Ucb, INC. | $75.49 | 2019-2024 | Cimzia |
| Pfizer INC. | $67.71 | 2023 | |
| Sandoz INC. | $40.24 | 2024 | Hyrimoz |
| Aurinia Pharma U.S., INC. | $29.07 | 2023 | Lupkynis |
| Alexion Pharmaceuticals, INC. | $27.70 | 2024 | Strensiq |
| Organon LLC | $24.47 | 2024 | |
| Lilly USA, LLC | $23.38 | 2024 | Taltz |
| Fresenius Kabi USA, LLC | $18.80 | 2023 | Idacio |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.68 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.98 | 2024 | Cyltezo |
| Genzyme Corporation | $13.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Pullman Mooar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.